Document Detail

Bisphosphonate safety and efficacy in chronic kidney disease.
MedLine Citation:
PMID:  23018824     Owner:  NLM     Status:  In-Data-Review    
A new population-based study of elderly patients hospitalized for a fracture and treated with an oral bisphosphonate finds no increased risk of acute kidney injury. The safety and efficacy of bisphosphonates may be different in patients with chronic kidney disease (CKD). The effects on vascular calcifications need further study, because low bone turnover might exacerbate vascular calcifications in patients with CKD. Even if bisphosphonates prove safe, their efficacy in this population is uncertain.
Susan M Ott
Related Documents :
16077254 - Proximal metatarsal osteotomy and distal soft tissue reconstruction as treatment for ha...
23838024 - Safety issues with bisphosphonate therapy for osteoporosis.
20037874 - Outcome of olecranon osteotomy in the trans-olecranon approach of intra-articular fract...
19941664 - Sagittal realignment osteotomy for increased posterior tibial slope after opening-wedge...
22972614 - In vitro evaluation of tat-op1 osteogenic properties and prospects for in vivo applicat...
15777334 - Blood-filled spaces with and without deproteinized bone grafts in guided bone regenerat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Kidney international     Volume:  82     ISSN:  1523-1755     ISO Abbreviation:  Kidney Int.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  833-5     Citation Subset:  IM    
Department of Medicine, University of Washington, Seattle, Washington, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Enhancing Oral Health via Sense of Coherence: A Cluster-randomized Trial.
Next Document:  Mononuclear phagocyte depletion strategies in models of acute kidney disease: what are they trying t...